Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1905083 | 0.88 | CYP3A4 (0.32) | CYP3A4CYP2D6 | |
| SCHEMBL30250913 | 0.88 | CYP3A4 (0.32) | CYP3A4CYP2D6 | |
| SCHEMBL2914677 | 0.88 | CYP3A4 (0.36) | CYP3A4CYP2D6CA12CA9PTGS1 | |
| SCHEMBL29659210 | 0.88 | CYP3A4 (0.36) | CYP3A4CYP2D6CA12CA9PTGS1 | |
| SCHEMBL4887381 | 0.84 | CYP3A4 (0.31) | CYP3A4CYP2D6 | |
| SCHEMBL4887287 | 0.81 | CYP3A4 (0.32) | CYP3A4CYP2D6 | |
| SCHEMBL9255038 | 0.80 | CYP2D6 (0.43) | CYP3A4CYP2D6CA12CA9PTGS1 | |
| SCHEMBL29208887 | 0.79 | MAPT (0.32) | CYP3A4CYP2D6 | |
| SCHEMBL23350471 | 0.78 | CYP3A4 (0.33) | CYP3A4CYP2D6CA12CA9 | |
| SCHEMBL20792007 | 0.78 | CYP3A4 (0.33) | CYP3A4CYP2D6CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084559-B2 | Ethylene-vinylcyclohexane copolymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | AOC2, ACSL1, ACSL3 | CYP3A4 147/4885CYP2D6 297/4885CA12 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.